News By Tag
* Enzyme Activity Assay
* Cell Based Assay
* High-throughput Screening
* More Tags...
News By Location
Gyrasol Technologies Novel TDP-1 Assays in High Throughput Screening
The assay was developed in collaboration with scientists at Gyrasol Technologies and the Translational Drug Discovery Group, School of Life Sciences, University of Sussex, Brighton UK, who used Gyrasol’s detection platform technology to develop the robust oligonucleotide screening system, providing a rapid and inexpensive alternative to current methods for screening drugs that act on Tyrosyl-DNA-
The Gyrasol detection platform has a number of key features that in combination make it uniquely suitable for drug discovery:
· rapid and direct
· compatible with tissue samples
· suitabile for robotic screening
About Gyrasol Technologies
Gyrasol is a private company that offers expert custom assay development services. A range of commercial enzyme activity assays for drug discovery and systems biology research are provided through distributors including BioVision, Axxora/Enzo, and EMD.
Gyrasol Technologies Inc